Sex hormone binding globulin concentration as a prepubertal marker for hyperinsulinaemia in obesity
Open Access
- 1 December 2001
- journal article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 85 (6) , 489-491
- https://doi.org/10.1136/adc.85.6.489
Abstract
BACKGROUND Overweight children become obese adults who are prone to develop the “metabolic syndrome” and premature coronary arterial disease (CAD). AIMS To assess whether sex hormone binding globulin (SHBG) is a potential marker for hyperinsulinaemia/insulin resistance in prepubertal obese children. METHODS Twenty five obese children (body mass index (BMI) >2SD) who warranted investigation on clinical grounds were enrolled. Their insulin response to an oral glucose tolerance test was assessed. RESULTS Fourteen children were hyperinsulinaemic. Despite being matched for age and BMI, SHBG concentrations were below the sex related reference range in the hyperinsulinaemic group. CONCLUSION Our results indicate that a subnormal SHBG concentration in a prepubertal child is strongly predictive of hyperinsulinaemia. By measuring the circulating SHBG concentration, it might be possible to identify those at most risk of premature CAD, targeting them for lifestyle changes.Keywords
This publication has 7 references indexed in Scilit:
- Relation between obesity from childhood to adulthood and the metabolic syndrome: population based studyBMJ, 1998
- Longitudinal changes in cardiovascular risk from childhood to young adulthood in offspring of parents with coronary artery disease: the Bogalusa Heart Study.1997
- Pubertal Changes in Insulin Secretion and Peripheral Insulin SensitivityHormone Research, 1997
- Sex differences in weight in infancyBMJ, 1996
- Overweight Prevalence and Trends for Children and AdolescentsArchives of Pediatrics & Adolescent Medicine, 1995
- Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance?Journal of Clinical Endocrinology & Metabolism, 1993
- Inhibition of Sex Hormone-Binding Globulin Production in the Human Hepatoma (Hep G2) Cell Line by Insulin and Prolactin*Journal of Clinical Endocrinology & Metabolism, 1988